Evidence map›Paper›PMID 35551547›Full record

ArticlePloS one2022

Survival of HT29 cancer cells is influenced by hepatocyte growth factor receptor inhibition through modulation of self-DNA-triggered TLR9-dependent autophagy response.

Bettina Bohusné Barta, Ágnes Simon, Lőrinc Nagy, Titanilla Dankó, Regina Eszter Raffay, Gábor Petővári, Viktória Zsiros, Anna Sebestyén, Ferenc Sipos, Györgyi Műzes

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Bettina Bohusné BartaDepartment of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
Ágnes SimonDepartment of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
Lőrinc NagyDepartment of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.ORCID 0000-0001-5278-1898
Titanilla Dankó1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Regina Eszter Raffay1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Gábor Petővári1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Viktória ZsirosDepartment of Anatomy, Histology and Embryology, Semmelweis University, Budapest, Hungary.
Anna Sebestyén1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Ferenc SiposDepartment of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.ORCID 0000-0002-2767-7746
Györgyi MűzesDepartment of Internal Medicine and Hematology, Semmelweis University, Budapest, Hungary.
Semmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HGFR activation drives the malignant progression of colorectal cancer, and its inhibition displays anti-autophagic activity. The interrelated role of HGFR inhibition and TLR9/autophagy signaling in HT29 cancer cells subjected to modified self-DNA treatments has not been clarified. We analyzed this complex interplay with cell metabolism and proliferation measurements, TLR9, HGFR and autophagy inhibitory assays and WES Simple Western blot-based autophagy flux measurements, gene expression analyses, immunocytochemistry, and transmission electron microscopy. The overexpression of MyD88 and caspase-3 was associated with enhanced HT29 cell proliferation, suggesting that incubation with self-DNAs could suppress the apoptosis-induced compensatory cell proliferation. HGFR inhibition blocked the proliferation-reducing effect of genomic and hypermethylated, but not that of fragmented DNA. Lowest cell proliferation was achieved with the concomitant use of genomic DNA, HGFR inhibitor, and chloroquine, when the proliferation stimulating effect of STAT3 overexpression could be outweighed by the inhibitory effect of LC3B, indicating the putative involvement of HGFR-mTOR-ULK1 molecular cascade in HGFR inhibitor-mediated autophagy. The most intense cell proliferation was caused by the co-administration of hypermethylated DNA, TLR9 and HGFR inhibitors, when decreased expression of both canonical and non-canonical HGFR signaling pathways and autophagy-related genes was present. The observed ultrastructural changes also support the context-dependent role of HGFR inhibition and autophagy on cell survival and proliferation. Further investigation of the influence of the studied signaling pathways and cellular processes can provide a basis for novel, individualized anti-cancer therapies.

Indexed as

NeoplasmsToll-Like Receptor 9ApoptosisAutophagyCell Line, TumorCell ProliferationDNAHT29 CellsHumansProto-Oncogene Proteins c-metDNAProto-Oncogene Proteins c-metTLR9 protein, humanToll-Like Receptor 9

Identifiers

PMID35551547
PMCPMC9098092
OpenAlexW4280588559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.